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Cone beam CT (CBCT) has been widely used for patient setup in image guided 
radiation therapy (IGRT). Radiation dose from CBCT scans has become a clinical 20 
concern. The purposes of this study are 1) to commission a GPU-based Monte 
Carlo (MC) dose calculation package gCTD for Varian On-Board Imaging (OBI) 
system and test the calculation accuracy, and 2) to quantitatively evaluate CBCT 
dose from the OBI system in typical IGRT scan protocols. We first conducted dose 
measurements in a water phantom. X-ray source model parameters used in gCTD 25 
are obtained through a commissioning process. gCTD accuracy is demonstrated by 
comparing calculations with measurements in water and in CTDI phantoms. 25 
brain cancer patients are used to study dose in a standard-dose head protocol, and 
25 prostate cancer patients are used to study dose in pelvis protocol and pelvis 
spotlight protocol. Mean dose to each organ is calculated. Mean dose to 2% voxels 30 
that have the highest dose is also computed to quantify the maximum dose. It is 
found that the mean dose value to an organ varies largely among patients. 
Moreover, dose distribution is highly non-homogeneous inside an organ. The 
maximum dose is found to be 1~3 times higher than the mean dose depending on 
the organ, and is up to 8 times higher for the entire body due to the very high dose 35 
region in bony structures. High computational efficiency has also been observed in 
our studies, such that MC dose calculation time is less than 5 min for a typical case. 
  
 
  40 
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1. Introduction 
 
Cone-beam CT (CBCT) is one of the most widely used image guidance system for image 
guided radiation therapy (Jaffray et al., 1999; Jaffray et al., 2002; McBain et al., 2006; 
Grills et al., 2008). Despite the great benefits of accurate patient positioning, the 45 
widespread use of CBCT produce a considerable amount of excessive radiation dose to 
patients (Islam et al., 2006; Wen et al., 2007; Song et al., 2008; Ding and Coffey, 2009). 
Even though the magnitude of the imaging dose per CBCT scan is small, especially 
compared to that of therapeutic dose, the cumulative dose over a long treatment course 
may not be negligible. Moreover, the imaging dose spreads over many critical organs, as 50 
opposed to the therapeutic dose that conforms well to the tumor area. These facts have 
raised a great concern about the associated radiation risks (Brenner et al., 2003). It is 
hence of importance to quantitatively assess CBCT doses to patients in a comprehensive 
manner, in order to better understand the severity of this issue, and to evaluate and 
manage the associated risks (Murphy et al., 2007; Alaei et al., 2010).  55 
Over the years, a lot of research efforts have been devoted to CBCT dose 
assessments. Among them, measurement-based methods utilize detectors, such as 
thermoluminescent dosimeters (TLDs) or ion chambers, to directly probe dose in CBCT 
scans. However, many of the researches were conducted in CTDI phantoms or other non-
realistic phantoms (Islam et al., 2006; Amer et al., 2007; Song et al., 2008). It is hence 60 
difficult to interpret the results in real patient cases, as the individual patient body 
geometry and compositions can greatly alter dose magnitudes and distributions. Although 
there are some measurements performed in anthropomorphic phantoms (Amer et al., 
2007; Palm et al., 2010; Haelga et al., 2012; Giaddui et al., 2013), the use of phantoms 
limited measurements to only a few spatial locations. Because of the highly 65 
heterogeneous nature of a CBCT dose distribution due to the relatively low x-ray beam 
energy, the dose measurements at few isolated points may not capture some key 
information, e.g. maximum dose value, and may bias the results, e.g. mean organ dose.   
Calculation-based approaches constitute another category of CBCT dose 
assessments. These methods compute dose distributions inside patients via certain 70 
calculation models. Of particular interest is Monte Carlo (MC) simulation. The 
calculation accuracy of this method has been well accepted due to its capability of 
modeling physical interactions between radiation and matter, as well as the system 
geometry (DeMarco et al., 2004; DeMarco et al., 2005; DeMarco et al., 2007; Ding et 
al., 2007; Ding and Coffey, 2009; Ding et al., 2010; Li et al., 2011b, a). Nonetheless, 75 
because of the statistical nature of the MC method, a large number of photons are 
required in a simulation to yield a desired level of precision. The associated long 
computation time hinders the wide application of this method for a systematic study of 
CBCT doses in patient groups.  
Recently, computer graphics processing unit (GPU) has been employed to accelerate 80 
MC simulations for radiation dose calculations (Badal and Badano, 2009; Jia et al., 2010; 
Hissoiny et al., 2011; Jia et al., 2011; Jahnke et al., 2012; Jia et al., 2012a; Jia et al., 
2012b). Particularly, x-ray photon transports in the kV energy range, e.g. in CT and 
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CBCT, have been greatly sped up using the GPU platform (Badal and Badano, 2009; Jia 
et al., 2012b). It was reported that it takes only minutes to conduct a CBCT dose 85 
calculation in a voxelized patient geometry using the gCTD package (Jia et al., 2012b). 
This will greatly facilitate the comprehensive study of CBCT doses in real patient cases 
with a relatively large of sample size.   
Yet, before conducting studies as such, it is necessary to validate the gCTD package 
in terms of dose calculation accuracy. Although the photon transport accuracy of gCTD 90 
has been previously established by comparing simulation results with those from EGSnrc 
(Kawrakow, 2000), the x-ray source model accuracy has not been investigated, which 
critically determines the realism of the generated photons before entering patient body 
and hence the overall dose calculation accuracy. Therefore, the first motivation of this 
paper is to commission the source model used in gCTD for the x-ray source in Varian 95 
On-Board-Imaging (OBI) system (Varian Medical Systems, Palo Alto, CA). The overall 
calculation accuracy will also be tested by comparing calculations with measurements. 
 The second motivation of this paper comes from the desire of comprehensively 
evaluating radiation dose from CBCT scans on a group of patients. It is expected that the 
dose distribution varies among patients to a large degree due to the different patient size, 100 
material, and relative locations between the patient and the x-ray source. Only when we 
study a large group of patients can we extract information to describe the CBCT dose in 
an objective manner. In this paper, CBCT dose distributions in three typical scan 
protocols of the OBI system will be calculated using the gCTD package. Relevant 
quantities will be computed to characterize the dose distributions, as well as inter- and 105 
intra-patient dose variations.  
 
2. Methods and Materials 
 
2.1 gCTD  110 
 
gCTD is an MC dose calculation package for fast and accurate CT/CBCT dose 
calculations (Jia et al., 2012b). It is developed on the GPU architecture under NVIDIA 
CUDA platform. gCTD transports photons in a voxelized patient geometry. Relevant 
photon physics in the diagnostic energy range, e.g. photoelectric effect, Rayleigh scatter, 115 
and Compton scatter, are included in the simulations. Electrons generated are not tracked 
and their energies are locally deposited. The implementations of gCTD are carefully 
tuned to achieve a high performance on the GPU platform. Specifically, Woodcock 
transport technique (Woodcock et al., 1965) is employed to reduce the tedious voxel 
boundary crossing during the photon transport. A GPU-friendly method is developed to 120 
sample Rayleigh scattering angles and Compton scattering angles, reducing 
computational burdens in these two frequently preformed steps. The photon transport 
accuracy of gCTD has been validated against EGSnrc (Kawrakow, 2000), another 
popular MC package with well accepted accuracy. Meanwhile, it is found that high 
computational efficiency has been achieved due to the vast parallel processing capability 125 
of a GPU and the highly optimized algorithm and implementations. Imaging dose 
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calculation for a Zubal head-and-neck phantom can be accomplished in ~17 sec with the 
average relative standard deviation of 0.4%.  
Source model is an important component in gCTD, which critically determines the 
overall dose calculation accuracy in real patient cases. In gCTD, a point x-ray source is 130 
utilized. The source property is characterized by its energy spectrum and its photon 
fluence map, e.g. the relative photon fluence intensity as a function of photon direction. 
This is an effective source model, in that both of these two quantities are employed to 
describe photon distributions after exiting the whole source and before entering the 
patient, regardless the detailed physical configurations inside the x-ray source. The 135 
validity of this model will be justified by the capability of successfully commissioning 
the model and using gCTD to compute dose in phantom cases. gCTD also supports 
realistic CBCT scan geometry, where the x-ray source rotates around the patient along a 
circular trajectory with defined source-to-axis distance. The start and the stop angles of 
the scan, and the number of x-ray exposures are also controlled by the user.  140 
 
2.2 Commission of gCTD 
 
Before applying gCTD for dose calculations in patient cases, it is necessary to 
commission the x-ray beam model. In this study, we focus on three typical scan protocols 145 
of Varian OBI system on a Trilogy linear accelerator, that are routinely used in our clinic 
for patient setup purpose. These protocols are standard-dose head protocol, pelvis 
protocol, and pelvis spotlight protocol. The physical parameters of these protocols are 
listed in Table 1. Because of different bowtie filters and x-ray energies employed in these 
protocols, each of them has to be commissioned individually following the procedures 150 
described below.  
 
Table 1. Parameters of CBCT scan protocols in our studies. 
Protocol 
Angular 
range 
(degree) 
Bowtie 
filter 
kVp 
mAs per 
projection 
Number of 
projections 
Standard-
dose head 
200 Full-fan 100 0.4 364 
Pelvis 360 Half-fan 125 1.04 660 
Pelvis 
spotlight 
200 Full-fan 125 2.0 364 
 
 
2.2.1 Source fluence map and energy spectrum 
 155 
For the source fluence map, we conduct a CBCT air scan with no object between the 
source and the imager. The mAs level in these air scans are purposely reduced from the 
values listed in Table 1 to avoid saturation of the imager readings. This approach is valid, 
since modifying the mAs only changes the overall photon numbers hitting on the imager, 
but not the spatial distribution. Hundreds of projection images are acquired in a scan. 160 
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These images are averaged to reduce noise level in the detected signals. The resulting 
image is regarded as the photon fluence map used in gCTD. 
As for the energy spectrum, it is determined by comparing dose measurements and 
calculations in a water phantom. Specifically, we first conduct radiation dose 
measurements in a physical water phantom using a PTW waterproof farmer chamber 165 
N30013, which is calibrated at the kV energy range. The x-ray source is fixed at one 
direction such that the beam impinges to the phantom normally. Tube mAs level of 𝐼! = 5  mAs is used, which gives high enough readings while avoiding overheating the x-
ray tube from repeated measurements. The source-to-surface distance (SSD) is set to 85  cm. The reduced SSD from a typical setting of 100  cm increases photon fluence and 170 
hence chamber readings. We acquire chamber reading 𝑐(𝑧) as a function of depth 𝑧 in 
water along the central axis of the beam.  
Meanwhile, MC dose calculation is conducted using a homogenous water phantom 
of dimension 50.75  ×  50.75  ×  50.75  cm! and the voxel size is 0.25  ×  0.25  ×  0.25  cm!. 
The source location relative to the phantom is set identical to that in the experiment. In 175 
each run of the MC simulations for commissioning, 10!" source photons are simulated to 
yield results with a high precision. The photon fluence map obtained previously is used. 
The photon source spectrum is generated by a model developed by Boone et. al. (Boone 
and Seibert, 1997), with the kVp value set to the one used in the experiment. To 
determine the source spectrum, we choose Al as the source filtration material and tune 180 
the filtration thickness, until a good match between the calculated depth dose curve and 
the measured chamber reading is observed. The choice of Al as the filtration material is 
because the x-ray tube in the OBI system has 2mm Al filtration and the bowtie filter is 
made of Al as well (Varian Medical Systems, 2008). It is expected that by varying the 
thickness of Al filtration we could capture the major property of the source and hence get 185 
a good match between the simulation results and the measurements. Note that there is an 
overall scaling factor between the calculated results and the chamber reading due to 
different units in the two quantities, nC for the measurements 𝑐 𝑧  and keV/g per source 
photon for the MC simulation results 𝑑!"(𝑧). The two data sets are first normalized by 
their own mean values before making comparisons to remove the impacts of the different 190 
units. 
 
2.2.2 Absolute dose calibration 
 
Once the source spectrum and fluence map are obtained, we proceed to absolute dose 195 
calibration, which converts the MC calculated results into physical dose values in a unit 
of cGy. As such, we follow the procedure described in AAPM task group report 61 (Ma 
et al., 2001) to convert ion chamber measurements 𝑐 𝑧  into absolute dose in water 𝑑(𝑧). 
In this process, correction factors are applied to correct raw chamber reading 𝑐 𝑧  for, 
e.g. temperature and pressure, ion recombination, and chamber polarity. Dose in water is 200 
obtained by applying the mass energy absorption coefficient ratio of water to air [𝜇!"/𝜌]!"#!"#$%, which is calculated using the listed mass energy absorption coefficient in 
the XCOM database (Berger et al., 2010) and the previously obtained source energy 
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spectrum. The measured dose value is further normalized by the mAs level used in 
experiments 𝐼! = 5mAs, yielding dose per unit mAs, in a unit of cGy/mAs.  205 
After that, a calibration factor 𝑓, which maps the MC calculation results into the 
actual dose values per mAs, is determined by using a least square fit, min  |𝑑 𝑧 −𝑓𝑑!"(𝑧)|!. This has a closed form expression of 𝑓 = 𝑑 𝑧 ,𝑑!"(𝑧) / 𝑑!" 𝑧 ,𝑑!"(𝑧) , 
where . , .  denotes vector inner product. The determination of this calibration factor 𝑓 
utilizes dose measurements at all depths, as opposed to the depth of 2 cm suggested by 210 
the task group report 61, to reduce the impacts of inaccuracy associated in measurements 
and noise in MC simulations at a single point.  
 
2.3 Validation of gCTD 
 215 
2.3.1 Water phantom  
 
We first validate the dose calculation in the water phantom. Specifically, we use a single 
x-ray projection with 𝐼 = 5mAs and corresponding kVp value and bowtie filter in the 
CBCT protocol. We measure point dose using the ion chamber at depth 𝑧 = 2  cm, and 220 
laterally 5  cm away from the central beam axis along the x and the y direction, where the 
coordinate system is illustrated in Figure 2(a). For the protocols using the full-fan bowtie 
filter, since the dose is expected to be approximately symmetric about the y axis, only 
dose at positive x side is measured. For the protocol with the half-fan bowtie filter, doses 
at both the positive and the negative x sides are measured. In all protocols, since dose 225 
does not vary significantly along the y direction, only one measurement at the positive y 
side is measured. The chamber readings are converted to dose in water following the 
standard procedure.  
MC dose calculations in water are also conducted with 10! source photon simulated. 
Calculated 3D dose distribution is converted to physical dose using the 𝑓  factor 230 
established previously and the 𝐼 = 5mAs used in the experiment. Dose values at the 
measured locations are then extracted from the 3D dose array. The measured value 𝑑!"#$%&" and the MC calculated values 𝑑!"  are compared, and relative error is reported 
as 𝑒 = 𝑑!" − 𝑑!"#$%&" /𝑑!"#$%&" to characterize the agreement between them.  
 235 
2.3.2 CTDI phantom  
 
We further validate gCTD dose calculations in a nested CTDI phantom (10  cm diameter 
cylinder phantom nested in a 16  cm diameter cylinder phantom) made of acrylic. Five 
readings are taken, one at the center, and four at periphery at radius 𝑟   =   4  cm. The 240 
locations of each measurement are illustrated in Figure 1. For the pelvis mode, the 4 
periphery measurements are expected to be the same due to rotational symmetry. Hence 
only one reading at the location number 2 is taken. The chamber readings are converted 
to dose in the acrylic medium using the mass energy absorption coefficient ratio with 
necessary chamber reading corrections.  245 
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As for the MC simulations, we created a digital phantom with the same size to the 
CTDI phantom. The material is set to acrylic and the density is its nominal value of   𝜌 = 1.19  g/cm!.  MC dose calculations in this phantom are conducted using 10! source 
photon. The calculated dose values at the measurement locations are compared with the 
experimental ones, and the relative errors are calculated. 250 
 
 
2.3.3 CBDI calculations 
 
Third, we validate gCTD by calculating cone beam dose index (CBDI) and comparing 255 
the results with those published in literature. In this study, we created an acrylic CTDI 
phantom with 16  cm diameter for the head protocol, and with 32  cm diameter for the 
pelvis protocol. Dose calculations are conducted under the corresponding protocols, and 
dose values at the center, as well as four peripheral locations that are 1  cm away from the 
phantom boundary, are obtained. The measured central and the average of the four 260 
peripheral measurements are regarded as 𝐶𝐵𝐷𝐼!""!"#$"%  and 𝐶𝐵𝐷𝐼!""!"#$!!!" , respectively 
(Hyer and Hintenlang, 2010). The subscript 100 denotes an average of dose in a 100 mm 
range along the superior-inferior direction for each measurement. 𝐶𝐵𝐷𝐼!""! = !!𝐶𝐵𝐷𝐼!""!"#$"% + !!𝐶𝐵𝐷𝐼!""!"#$!!!"  is also calculated, which represents the 
average dose in the phantom. These calculated values are compared with those reported 265 
by Hyer et. al. (Hyer and Hintenlang, 2010), that are obtained by chamber measurements. 
Pelvis spotlight protocol is not studied here, since the values were not reported in that 
article.  
 
2.3 CBCT dose in current clinical protocols 270 
 
We proceed to evaluate CBCT dose in real patient cases, after establishing the calculation 
accuracy of gCTD. Two groups of patients are selected to investigate doses in the 
 
Figure 1. Illustrations of the CTDI phantom used in our experiments. Arrows indicate x-ray 
source range in the standard-dose head protocol and the pelvis spotlight protocol. 
16#cm#
4#cm#
#1#
#2#
#5#
#3# #4#
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aforementioned three protocols. Specifically, 25 adult brain cancer patients were selected 
to evaluate doses in the standard-dose head protocol. These patients were treated at our 275 
institution with intensity-modulated radiation therapy (IMRT), and experienced CBCT-
based patient setup before treatments. Another 25 adult prostate cancer patients were also 
selected to evaluate doses in the pelvis and the pelvis spotlight protocols. These patients 
receive IMRT treatments and CBCT-guided patient positioning with the pelvis protocol 
per the treatment protocol at our institution. However, we also compute doses from the 280 
spotlight protocol on these patients as a hypothetical study regarding the doses in that 
protocol.  
For each of the patients, we first extract the CT image used in radiotherapy 
treatment planning. The CT number at each voxel is converted into density value and 
material type based on the calibration curve for our CT scanner. Treatment isocenter is 285 
also obtained from the radiotherapy plans, which is assumed to be the isocenter of the 
CBCT scans. After that, we conduct MC dose calculations using the source spectrum and 
fluence map corresponding to the scan protocol. 10! source photons are used to yield an 
acceptable level of uncertainty. The resulting dose distribution is converted to the 
absorbed dose per CBCT scan by multiplying with the 𝑓 factor and the total mAs level 290 
for the scan.  
Because of the available organ contours associated with those patients for IMRT 
treatment planning purpose, we can evaluate organ doses based on the calculated 3D dose 
distributions. As such, we first compute the mean dose 𝑑 of an organ of interest by 
simply averaging dose values over all voxels inside the organ. The mean dose value is 295 
further averaged over all patients, 𝑑 , to represent a typical dose to this organ from this 
protocol. Because of the variations among patient size, anatomy, and relative locations of 
CBCT isocenter to organs, dose to organs varies among patients. We characterize the 
inter-patient dose variability by 𝜎 = Δ𝑑/ 𝑑 , where Δ𝑑 is the range of 𝑑 among patients 
for the organ of interest. The larger 𝜎 is, the larger the dose varies among patients. 300 
Meanwhile, it is also expected that the dose distribution inside an organ is not spatially 
homogeneous. To characterize this fact, we first compute the mean dose to those 2% of 
voxels inside the organ that receive the highest doses, denoted as 𝑑!%. This quantity 
characterizes the maximum dose inside this organ to a certain extent. Note that we do not 
use the maximum dose value directly, because it is the dose to a single voxel and may 305 
have relatively large fluctuations in a MC calculation. 𝑑!% is then averaged over all 
patients, yielding 𝑑!% . Finally, the intra-patient dose variability is represented by 𝜂 = 𝑑!% / 𝑑 . The higher 𝜂 is, the more dramatic the dose fluctuates spatially.   
 
3. Results 310 
 
3.1 gCTD calibration 
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We first show in Figure 2 the commissioned effective source spectrums and the fluence 315 
maps for the three protocols. These results are obtained by tuning the Al filtration 
thickness to yield the best match between the calculated and the measured depth dose 
curves in water. The quality of this matching is also shown in Figure 2 (g)~(i).  
For the standard-dose head protocol, the best fit between experiments and 
calculations is achieved at 4.1 mm Al. In fact, the x-ray tube itself has 2 mm of 320 
equivalent Al filtration at the exit window (Varian Medical Systems, 2008). For the full-
fan bowtie-filter used in this protocol, the thickness of the filter at the middle point is 
~1.6 mm. The additional filtration observed in our calibration can be ascribed to other 
components along the beam path as well as source scattering, which effectively increases 
the beam depth dose curve and hence the effective filtration thickness.  325 
For the pelvis spotlight protocol, the effective filtration thickness is also found to be 
4.1 mm Al. Comparing this protocol with the standard-dose head protocol, they have the 
same bowtie-filter but different kVp values. Because of the same source inherent 
filtration and the same bowtie-filter, it is reasonable that the same effective filtration 
thickness is obtained in our commissioning. On the other hand, the effective filtration of 330 
the pelvis mode is 4 mm Al. This value is slightly different from those in the other two 
protocols, which could be due to the different bowtie-filter used in this mode.  
Once the source spectrum and the fluence map is determined, we conducted absolute 
dose calibrations to determine the 𝑓 factor that maps the MC calculated dose values into 
the actual physical dose values. We do not list the 𝑓 values here, as the values are only 335 
 
Figure 2. (a)~(c), fluence maps in head, pelvis, and pelvis spotlight protocols, respectively. 
(d)~(f) spectrums for the three protocols determined through the calibration process. (g)~(i) 
Comparisons of the calculated and the measured depth dose curves in the three protocols. 
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applicable to our MC-code and this calibration process. Hence, reporting the values does 
not have a general meaning. 
 
3.2 gCTD validations 
 340 
To demonstrate the calculation accuracy of gCTD after this commissioning process, we 
first conducted the measurements in a water phantom at depth 𝑧 = 2  cm at different x 
and y coordinates. The calculated and measured dose values are listed in Table 2. The 
relative difference is maintained to be within a few percent, which demonstrates the 
acceptable accuracy achieved in this case. 345 
 
Table 2. Comparison of the calculated and the measured doses in water. 
 
Protocol 
Coordinate (𝑥, 𝑦)  
(cm) 
Measured 
(mGy) 
Calculated 
(mGy) 
𝑒  
 (%) 
Standard-
dose head 
(5, 0) 0.255 0.263 3.1 
(0, 5) 0.573 0.588 2.5 
Pelvis 
spotlight 
(5, 0) 0.489 0.497 1.6 
(0, 5) 1.002 1.039 3.7 
Pelvis 
(-5, 0) 1.101 1.174 6.6 
(5, 0) 0.856 0.921 7.6 
(0, 5) 1.108 1.117 3.2 
 
 
For the validation study conducted in the CTDI phantom with 16 cm diameter, the 
results are summarized in Table 3. Again, the calculated and the measured doses are in 
good agreement, such that a few percent of relative dose difference is obtained.  350 
Table 3. Comparison of the calculated and the measured doses CTDI phantom. 
 
Protocol 
Location 
number 
Measured 
(cGy) 
Calculated 
(cGy) 
𝑒  
 (%) 
Standard-
dose 
head 
1 0.576 0.590 2.5 
2 0.376 0.367 -2.3 
3 0.706 0.703 -0.5 
4 0.531 0.559 5.2 
5 0.792 0.853 7.8 
Pelvis 
spotlight 
1 5.233 5.489 4.9 
2 3.239 3.434 6.0 
3 5.787 5.877 1.6 
4 5.202 5.528 6.3 
5 7.079 7.650 8.1 
Pelvis 
1 5.480 5.693 3.9 
2 5.822 5.619 -3.5 
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Finally, Table 4 lists the results of CBDI values for the standard-dose head and the 
pelvis protocols. The reported CBDI values are taken from (Hyer and Hintenlang, 2010). 
Considering the uncertainty in measurements, the calculations and the measurements 
agree well. 
 355 
Table 4. Comparison of the calculated and the measured CBDI values. 
 
 
Reported 
(mGy) 
Calculated 
(mGy) 
𝑒  
 (%) 
Standard-
dose 
head 
𝐶𝐵𝐷𝐼!""!"#$"% 5.34 5.43 1.7 𝐶𝐵𝐷𝐼!""!"#$!!!"# 5.09 5.85 14.9 𝐶𝐵𝐷𝐼!""!  5.17 5.71 10.4 
Pelvis 
𝐶𝐵𝐷𝐼!""!"#$"% 14.38 16.87 17.3 𝐶𝐵𝐷𝐼!""!"#$!!!"# 25.17 26.26 4.3 𝐶𝐵𝐷𝐼!""!  21.57 23.13 7.1 
 
 
3.3 Patient studies in current CBCT protocols 
 
A typical dose distribution of the HN patient is shown in Figure 3. The dose distribution 
is displayed in color scale overlaid with the patient CT image shown in gray scale. A few 360 
properties are apparent in these images. First, the dose to the eyes is low due to the 200° 
scan angle, in which the x-ray tube travels posteriorly to the patient head. Second, 
because of the low x-ray energy, the dose distribution is highly non-homogeneous. It 
decays fast as penetrating through the patient body. The inhomogeneity is exacerbated by 
the high photoelectric effect cross section of bones compared to tissues, making the dose 365 
to bones a few times higher than to nearby tissues, as clearly indicated by the dose profile 
plots in Figure 4.  
 
 
 
Figure 3. Dose distribution from a CBCT scan with the standard-dose head protocol. Dash lines in 
(a) are axes on which profiles in Figure 4 are plotted. 
(a)$ (b)$ (c)$
x 
y z 
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 370 
Because of the availability of organ contours, we are able to compute mean dose per 
scan to these organs for the 25 patients we studied. Here, we report the mean organ dose 𝑑  averaged over all the patients, as well as the range of this value among all patients. 
The results are listed in Table 5. It is apparent that the dose level is low in a CBCT scan. 
Meanwhile, 𝜎 = Δ𝑑/ 𝑑  is found to be 0.50~2.21, indicating that mean dose to an organ 375 
varies significantly among patients. As for the mean dose to those 2% of voxels with the 
highest doses inside each organ, it is much higher than the mean dose to that organ. The 
average value over all patients, as well as its range among patients are also listed in Table 
5. We further compute the ratio of 𝜂 = 𝑑!% / 𝑑 . It is found that 𝜂 ranges from 1.33 to 
2.60 depending on organs. However, for the entire body, 𝜂 goes up to over 8, which can 380 
be ascribed to the higher dose to bony structures.  
 
 
For the pelvis and the pelvis spotlight protocols, we display the dose distributions 
for a typical prostate cancer patient case in Figure 5 and the profiles along three axes in 385 
Figure 6. When comparing the two results, it is clear that the dose distribution in the 
spotlight protocol is more posteriorly located due to the x-ray source motion trajectory. 
This fact inevitably increases dose to rectum and reduces dose to bladder.  
 
 
Figure 4. Dose profile (solid) and density profile (dash) along the axes shown in Figure 3. 
 
Table 5. Organ doses for the standard-dose head protocol. 
 
Organ 
𝑑  
(cGy) 
Range of 𝑑 
(cGy) 
𝑑!%  
(cGy) 
Range of 𝑑!% 
(cGy) 
𝜂 𝜎 
Brain 0.27 0.19~0.33 0.48 0.36~0.59 1.81 0.50 
Brainstem 0.26 0.14~0.34 0.35 0.24~0.43 1.33 0.75 
Chiasm 0.21 0.13~0.26 0.30 0.16~0.87 1.46 0.68 
Eyes 0.093 0.03~0.24 0.13 0.06~0.31 1.39 2.21 
Optical 
nerves 
0.14 0.07~0.25 0.37 0.11~0.71 2.60 1.27 
Body 0.33 0.20~0.47 2.74 2.11~3.34 8.34 0.83 
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 390 
The quantitative characterizations of dose to organs are listed in Table 6 and Table 7 
for these two protocols, respectively. Again, the dose is highest in bony structures, e.g. 
femoral heads. As for the absolute dose comparisons between the two protocols, the 
average dose to rectum in the spotlight protocol is higher than that in the pelvis protocol, 
caused by the higher mAs per projection in the spotlight protocol and the posteriorly 395 
located x-ray source. In contrast, the average dose to bladder in the pelvis protocol is 
higher. For the dose homogeneity inside each organ, the 𝜂 parameter indicates that dose 
distributions in most organs are not homogeneous. However, that of the rectum and of the 
bladder in the pelvis protocol is more homogeneous compared with other organs, which 
can be ascribed to a large scan angle and the shallow organ locations. This fact can also 400 
be observed by visually comparing Figure 4 (a) and (d). The inter-patient dose variability 
is also found to be large, such that 𝜎 can be up to 1.80. 
 
 
 405 
 
Figure 5. (a)~(c) dose distribution from a pelvis protocol. (e)~(f) dose distribution from a pelvis 
spot-light protocol. 
 
 
Figure 6. Dose profiles for the pelvis protocol (solid), those for the pelvis spotlight protocol 
(dash-dot), and density profiles (dash) along the axes shown in Figure 5. 
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3.3 Computation time 
 
One of the advantages of using GPU-based MC dose engine is its fast processing speed. 410 
The dose calculation time obviously depends on patient size. In our study, all the patient 
cases have 256×256 voxels inside the transverse plane, and the voxel number along the 
superior-inferior direction ranges from 100 to 220. We have achieved a satisfactory 
speed. It takes less than 5 minutes on an Nvidia GTX 590 card to perform dose 
calculations with 10!  source photons for all the patient cases. The average relative 415 
uncertainties for those cases are found to be less than 1%.  The reason why we simulate 10! source photons is because we would like to have an accurate 𝑑!% result, which is a 
quantity that is averaged over only a small number of voxels. It is hence sensitive to MC 
noise. If one were only interested in the mean dose to an organ, much fewer source 
photons would be sufficient, as the result is robust against MC uncertainty because of the 420 
average over many voxels.  The computational time would also be shortened accordingly.  
There are other steps in dose calculations, e.g. extracting doses to voxels inside 
organs of interest, and computing the mean dose and the average top 2% dose.  However, 
compared to the MC step, the time spent on other steps is negligible.  
 425 
 
 
Table 6.  Organ doses for the pelvis protocol. 
 
Organ 
𝑑  
(cGy) 
Range of 𝑑 
(cGy) 
𝑑!%  
(cGy) 
Range of 𝑑!% 
(cGy) 
𝜂 𝜎 
Prostate 2.04 1.16~3.06 4.69 2.36~10.52 2.04 0.94 
Rectum 2.18 1.44~2.88 2.61 1.76~3.56 1.22 0.66 
Bladder 2.13 1.15~3.15 2.82 1.42~4.10 1.23 0.94 
Femoral 
heads 
2.96 1.98~5.20 8.09 5.34~11.38 2.69 1.09 
Body 1.21 0.66~2.08 6.16 3.13 4.69 1.17 
 
Table 7.   Organ doses for the pelvis spotlight protocol. 
 
Organ 
𝑑  
(cGy) 
Range of 𝑑 
(cGy) 
𝑑!%  
(cGy) 
Range of 𝑑!% 
(cGy) 
𝜂 𝜎 
Prostate 1.79 1.06~2.55 3.87 2.28~5.81 2.16 0.83 
Rectum 2.87 1.89~3.66 3.90 2.62~5.53 1.36 0.62 
Bladder 1.09 0.41~2.36 1.97 0.71~3.36 1.81 1.80 
Femoral 
heads 
2.62 1.85~6.16 6.80 2.22~10.44 2.59 1.64 
Body 1.16 0.61~2.02 6.96 4.57~11.59 6.00 1.22 
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4. Conclusion and Discussions  
 
In this paper, we have commissioned a previously developed GPU-based MC package, 430 
gCTD, for CBCT imaging dose calculations. Source model parameters are obtained for 
three typically used CBCT protocols. The calculation accuracy is demonstrated by 
comparing the results with dose measurements. Through patient studies, doses to key 
organs in these three scan protocols are evaluated. It is found that the mean dose value to 
an organ varies largely among patients. Moreover, dose distribution is highly non-435 
homogeneous inside an organ. The maximum dose is found to be 1~3 times higher than 
the mean dose for those critical organs, and is up to 8 times higher for the entire body due 
to the presence of bony structures. High computational efficiency was also observed in 
our studies, such that MC dose calculation time is less than 5 min for a typical case with 10! source photons simulated. 440 
As for the clinical implications of the observed dose values, it is apparent that the 
doses reported in the three protocols are very small. The mean dose to an organ is of the 
order of mGy to cGy. However, whether or not these dose levels are of clinical concern 
will be subject to the specific context. If daily CBCT is repeatedly conducted on a patient 
during a long treatment course, the total dose may not be negligible and may require 445 
specific managements (Alaei et al., 2010). On the other hand, for a treatment course with 
only a few fractions, e.g. stereotactic radio-surgery, the imaging dose may be neglected, 
particularly considering the high therapeutic dose delivered per fraction. Other issues 
such as spatial inhomogeneity of the dose distributions may also call for attentions. The 
maximum dose to an organ could be a clinical concern, although the high dose region is 450 
of a small area. Repeated CBCT scans will also likely smear the total dose distribution 
and reduce the maximum dose relative to the mean dose due to the patient position shift 
among different scans. 
We would also like to remark on the accuracy of our calculations. Even though the 
accuracy of gCTD has been verified to a certain extent in the first half of this paper, the 455 
accuracy in real patient cases may also be limited by other practical factors, such as 
conversion from CT number to material properties. Compared to previous published 
CBCT dose data from measurements and from MC calculations, the organ dose values 
reported in this manuscript agrees with them sometimes only in terms of order of 
magnitude, whereas the absolute quantities are different. Yet, this fact can be ascribed to 460 
a few factors. First, the measurement itself could have uncertainty to a certain degree. 
Second, the dose values highly depend on the location because of the spatial dose 
inhomogeneity. Third, the large inter-patient dose variability due to patient size and iso-
center locations lead to vary patient-dependent results. In light of these facts, the doses 
obtained in our studies should be accepted only semi-quantitatively, whereas the numbers 465 
should not be taken as exact values.  
Nonetheless, there are some features revealed by our studies, which should hold in 
general. Specifically, the observed large inter- and the intra- patient dose variability are 
expected to be true in general. The inter-patient organ-dose variability is mainly caused 
by patient size and anatomy and relative locations of isocenter to organs, while the intra-470 
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patient variability is due to the low-energy x-ray and the anatomical inhomogeneity. 
Based on these findings, it may be necessary to report quantities other than the mean dose 
to an organ in order to objectively characterize the organ dose. This fact also 
demonstrates the necessity of patient-specific CBCT dose calculations, as proposed by 
many researches recently (Bacher et al., 2005; Li et al., 2011b, a; Jia et al., 2012b).  475 
Regarding the technical developments, our study demonstrated the feasibility of 
using the MC method to accurately and efficiently compute imaging dose distributions to 
patients. In particular, the short MC computation time is likely to be acceptable for 
integration into a clinical environment for patient-specific dose calculations. Nonetheless, 
we would also like to point out that automatic organ contouring remains to be a 480 
challenging problem, if organ-related dose quantities are desired. This will require further 
development in the future.  
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